Prognostic Significance of Cancer Stem Cell Markers in Patients With Salivary Gland Carcinomas Publisher Pubmed



Sadeghi H¹ ; Saffar H³ ; Taheri P¹ ; Yazdani F⁴ ; Etebarian A² Show Affiliations
Source: Applied Immunohistochemistry and Molecular Morphology Published:2022

Abstract

Objectives: Cancer stem cells (CSCs) are a small group of cells resistant to therapy and play a major role in tumor progression, recurrence, and poor clinical outcomes of patients. This study aimed to evaluate the association of CSC markers with clinicopathologic features and survival in patients with salivary gland carcinomas (SGCs). Materials and Methods: The medical records of 48 patients affected by mucoepidermoid carcinoma (MEC) and 47 patients with adenoid cystic carcinoma (AdCC) were reviewed retrospectively. SOX2, CD133, and CD44 expression was appraised by immunohistochemistry and statistically analyzed to weigh the correlation between these markers and patients' clinicopathologic features and tumor outcomes. Results: In AdCC patients showing poor outcomes, a trend toward a high expression of CD133 and CD44 and low expression of SOX2 was observed, while in MEC patients experiencing the same outcomes, there was a trend toward a high expression of CD44 and low expression of CD133 and SOX2. Only the increase of MEC histopathologic grade was statistically significant with decreased SOX2 expression. Distant metastasis in AdCC patients, tumor grade, lymph node involvement, and local recurrence in MEC patients had significant correlations with patients' survival. Conclusion: Besides the significant association between low SOX2 expression and higher grades of MEC, we found no statistically significant correlation between the studied CSC markers and patients' survival or clinicopathologic features. Therefore, a larger sample size with long-Term follow-up is beneficial for thorough investigations toward the main role of CSCs in patients with SGCs. © 2022 Lippincott Williams and Wilkins. All rights reserved.